Name | 4-(3,5-Diphenyl-4,5-dihydro-1H-pyrazol-1-yl)benzenesulfonamide |
---|---|
Synonyms |
4-(3,5-Diphenyl-4,5-dihydro-1H-pyrazol-1-yl)benzenesulfonamide
1-<4-Pyrrolidinomethyl-phenyl>-2-phenyl-6-methoxy-3,4-dihydronaphthalin-hydrochlorid Benzenesulfonamide, 4-(4,5-dihydro-3,5-diphenyl-1H-pyrazol-1-yl)- MLS-573151 |
Description | MLS-573151 (MLS000573151) is a selective GTPase Cdc42 inhibitor with an EC50 of 2 μM. MLS-573151 is inactive against other GTPases family members, such as Rab2, Rab7, H-Ras, Rac1, Rac 2 and RhoA wild-type. MLS-573151 acts by blocking the binding of GTP to Cdc42[1][2]. |
---|---|
Related Catalog | |
In Vitro | The fluorescence intensities of phagocytosed beads or bacteria in hemocytes, taken as a measure of phagocytosis efficiency, were markedly reduced in granulocytes treated with MLS-573151 (50 μM; for 15 min) compared to that in the control group. MLS-573151 could effectively inhibit the phagocytic ability of granulocytes[1]. |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 596.3±60.0 °C at 760 mmHg |
Molecular Formula | C21H19N3O2S |
Molecular Weight | 377.460 |
Flash Point | 314.5±32.9 °C |
Exact Mass | 377.119812 |
PSA | 84.14000 |
LogP | 1.90 |
Vapour Pressure | 0.0±1.7 mmHg at 25°C |
Index of Refraction | 1.669 |